Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Vinay Hosuru Siddappa

Orthopaedic Surgery Houston, TX Medical Doctor

NPI 1649641960 CMS profile 1347620

2002 Holcombe Blvd # 5C-288, Houston, TX 77030

Open in the dashboard

General payments

$26,152

296 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vinay Hosuru Siddappa of Houston, TX is reported in the CMS Open Payments database as having received $26,152 across 296 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,156 63
2024 General $3,018 70
2023 General $2,762 35
2022 General $4,949 41
2021 General $3,344 39
2020 General $2,631 20
2019 General $4,291 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vinay Hosuru Siddappa
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Vinay Hosuru Siddappa were reported at $5,156. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Vinay Hosuru Siddappa Orthopaedic Surgery median Middle half National median
2019 $4,291 $644 $140–$2,844 $163
2020 $2,631 $312 $75–$1,860 $114
2021 $3,344 $520 $117–$2,495 $132
2022 $4,949 $598 $128–$2,731 $149
2023 $2,762 $461 $128–$2,264 $160
2024 $3,018 $497 $134–$2,475 $164
2025 $5,156 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $10,573 116 payments
  2. Zimmer Biomet Holdings, Inc. $5,175 74 payments
  3. Medacta USA, Inc. $2,433 27 payments
  4. Medinc of Texas $2,257 6 payments
  5. Arthrex, Inc. $1,754 11 payments
  6. Acumed LLC $1,673 11 payments
  7. AxoGen $614 16 payments
  8. Paragon 28, Inc. $382 3 payments
  9. ERMI Inc. $350 3 payments
  10. Smith+Nephew, Inc. $185 3 payments
  11. Other $755 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $11,937 61 payments
  2. Food and Beverage $11,851 231 payments
  3. Education $2,348 3 payments
  4. Entertainment $16 1 payment
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $2,759 18 payments
  2. MAKO Knees, Hips $2,691 23 payments
  3. GMK SPHERE $1,664 12 payments
  4. PRIME SERIES $1,468 25 payments
  5. Oxford-Knees $1,203 11 payments
  6. Oxford $1,041 7 payments
  7. Trabecular Metal (TM) Ankle $986 7 payments
  8. Persona $970 13 payments
  9. OsteoMed $796 3 payments
  10. INBONE $644 6 payments
  11. Other $10,071 204 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

296 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record